000			01747 a2200493 4500
005			20250513135544.0
264		0	_c19980417
008			199804s 0 0 eng d
022			_a1130-0108
040			_aNLM _beng _cNLM
100	1		_aPérez Mota, A
245	0	0	_aHelicobacter pylori, efficacy of the new triple therapy in six and twelve-day schedules. _h[electronic resource]
260			_bRevista espanola de enfermedades digestivas _cDec 1997
300			_a879-84 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Randomized Controlled Trial
650	0	4	_aAmoxicillin _xadministration & dosage
650	0	4	_aAnti-Bacterial Agents _xadministration & dosage
650	0	4	_aAnti-Ulcer Agents _xadministration & dosage
650	0	4	_aClarithromycin _xadministration & dosage
650	0	4	_aDrug Administration Schedule
650	0	4	_aFemale
650	0	4	_aHelicobacter Infections _xdiagnosis
650	0	4	_aHelicobacter pylori _xisolation & purification
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aOmeprazole _xadministration & dosage
650	0	4	_aPenicillins _xadministration & dosage
650	0	4	_aTime Factors
650	0	4	_aTinidazole _xadministration & dosage
700	1		_aAlberdi, J M
700	1		_aPita, L
700	1		_aGalán, J L
700	1		_aGarcía Benito, M D
700	1		_aCrespo, L
700	1		_aBlanco, M A
700	1		_aGüemes, C
700	1		_aVillalgordo, C
700	1		_aCarnicero, J A
700	1		_aBeckford, C
700	1		_aPérez Muñoz, C
700	1		_aFernández Velázquez, J
700	1		_aCasanova, A
773	0		_tRevista espanola de enfermedades digestivas _gvol. 89 _gno. 12 _gp. 879-84
999			_c9462489 _d9462489